Mighty Therapeutics
Needham, US · 1 known investors
Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.
Founders & leadership
RM
Reenie McCarthyCEO
Investors · 1
Frequently asked questions
- What does Mighty Therapeutics do?
- Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.
- Who are Mighty Therapeutics's investors?
- Mighty Therapeutics's investors include K2 HealthVentures.
- Where is Mighty Therapeutics headquartered?
- Mighty Therapeutics is headquartered in Needham, US.